NFZ to allocate more funds to AOS and oncology
The National Health Fund (NFZ) has decided to amend its financial plan, as a result of which over PLN 1bn…
The National Health Fund (NFZ) has decided to amend its financial plan, as a result of which over PLN 1bn…
In 2020, spending on oncology in Poland will amount to PLN 11.2bn, announced the Ministry of Health. In early February…
The Ministry of Health has announced the introduction of new drugs both in drug programmes and on the pharmacy list…
Although Krakow has the only centre in Poland offering cancer treatment with proton therapy, children cannot use its services. The…
Over PLN 870m will be invested in the expansion and modernisation of the Warsaw branch of the Centrum Onkologii –…
The last few days have brought a lot of changes in the biotechnological company Selvita. The company’s shareholders agreed to…
Dr. Setareh Shamsili became the new Chief Medical Officer at Selvita. This is another personnel change in the Polish biotechnology…
Further personnel changes in the Polish biotechnology company Selvita. Dr. Tom Coulter has been appointed to the position of the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.